Accelerating Personalized, Curative Medicines with Cellular Proteomics
The future of immune medicine holds promise for lasting and durable impact on many diseases; our high resolution systems are powering the development and further personalization of these curative medicines.
Our Applications
Powering the Future of Personalized Medicine
Hardware and Software
Enabling All Labs to Access Our Applications
IsoLight Virtual Demo
Tour our easy to use benchtop instrument
IsoSpeak Virtual Demo
Tour our easy to use end-to-end software
Updates: Enabling a New Era of Precision Medicine
New Publications View All
- Changes in peripheral and local tumor immunity after neoadjuvant chemotherapy reshape clinical outcomes in patients with breast cancer
- Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice
- Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
Latest Customer Stories View All
- Understanding the Mechanisms of Neurological Complications in COVID-19 with IsoPlexis’ Functional Proteomics
- Cancer Resistance Timeline: How IsoPlexis’ Single-Cell Proteomics Can Predict Resistance and Enable Therapies to Combat Drug-Resistant Cell States
- Predicting and Overcoming Resistance Using IsoPlexis' Single-Cell Intracellular Proteomic and Metabolomic Analysis Tools
Enabling the Future of Personalized Medicine
Across Complex Diseases
Across Complex Diseases
See our 55 predictive data sets and 80+ publications across area of interest
The IsoLight is the Hub for All of Your Proteomic Applications
Multiple Chip Products: Many Applications
Single-Cell Secretome 
CodePlex Secretome 
Single-Cell Intracellular Proteome 
CodePlex Intracellular Proteome 
Single-Cell Metabolome 
CodePlex MetabolomeThe IsoLight
Meet your lab's daily proteomic needs through automation & software that provides ease of use
IsoSpeak Software
Meet your lab's daily proteomic needs through automation & software that provides ease of use
Join our global user community,
invent the future of medicine
invent the future of medicine
"Quality assays are mainly descriptive with some objective parameters like cytokine production, cytotoxicity, and proliferation. Only recently, with PSI… can we start to differentiate products."
Moffitt Cancer Center
"As a cancer research center with a key focus on CAR-T and other cell therapies, we feel that IsoPlexis will enable us to better characterize response and potentially predict whether cancer patients will respond to CAR-T therapy before treatment."
City of Hope
“The best way to predict the future is to invent it.”
— Alan Kay
